BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23253955)

  • 1. Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology.
    Halverson SJ; Kunju LP; Bhalla R; Gadzinski AJ; Alderman M; Miller DC; Montgomery JS; Weizer AZ; Wu A; Hafez KS; Wolf JS
    J Urol; 2013 Feb; 189(2):441-6. PubMed ID: 23253955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of renal mass biopsy risk stratification algorithm for robotic partial nephrectomy--could a biopsy have guided management?
    Rahbar H; Bhayani S; Stifelman M; Kaouk J; Allaf M; Marshall S; Zargar H; Ball MW; Larson J; Rogers C
    J Urol; 2014 Nov; 192(5):1337-42. PubMed ID: 24936720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal Tumors.
    Osawa T; Hafez KS; Miller DC; Montgomery JS; Morgan TM; Palapattu GS; Weizer AZ; Caoili EM; Ellis JH; Kunju LP; Wolf JS
    J Urol; 2016 Mar; 195(3):574-80. PubMed ID: 26523883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade.
    Blumenfeld AJ; Guru K; Fuchs GJ; Kim HL
    Urology; 2010 Sep; 76(3):610-3. PubMed ID: 20163843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma?
    Millet I; Curros F; Serre I; Taourel P; Thuret R
    J Urol; 2012 Nov; 188(5):1690-4. PubMed ID: 22998910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses.
    Shannon BA; Cohen RJ; de Bruto H; Davies RJ
    J Urol; 2008 Oct; 180(4):1257-61; discussion 1261. PubMed ID: 18707712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
    Abel EJ; Carrasco A; Culp SH; Matin SF; Tamboli P; Tannir NM; Wood CG
    BJU Int; 2012 Dec; 110(11):1742-6. PubMed ID: 22503066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention.
    Menogue SR; O'Brien BA; Brown AL; Cohen RJ
    BJU Int; 2013 Apr; 111(4 Pt B):E146-51. PubMed ID: 22805186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis.
    Barocas DA; Rohan SM; Kao J; Gurevich RD; Del Pizzo JJ; Vaughan ED; Akhtar M; Chen YT; Scherr DS
    J Urol; 2006 Nov; 176(5):1957-62. PubMed ID: 17070218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy.
    Leveridge MJ; Finelli A; Kachura JR; Evans A; Chung H; Shiff DA; Fernandes K; Jewett MA
    Eur Urol; 2011 Sep; 60(3):578-84. PubMed ID: 21704449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study.
    Breda A; Treat EG; Haft-Candell L; Leppert JT; Harper JD; Said J; Raman S; Smith RB; Belldegrun AS; Schulam PG
    BJU Int; 2010 Apr; 105(7):940-5. PubMed ID: 19888984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of percutaneous biopsy of the renal masses. 73 cases].
    Daniel L; Barriol D; Lechevallier E; André M; De Fromont M; Charafe E; Coulange C; Pellissier J
    Ann Pathol; 2000 Mar; 20(2):119-23. PubMed ID: 10740006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses.
    Rybicki FJ; Shu KM; Cibas ES; Fielding JR; vanSonnenberg E; Silverman SG
    AJR Am J Roentgenol; 2003 May; 180(5):1281-7. PubMed ID: 12704038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen.
    Barocas DA; Mathew S; DelPizzo JJ; Vaughan ED; Sosa RE; Fine RG; Akhtar M; Scherr DS
    BJU Int; 2007 Feb; 99(2):290-5. PubMed ID: 17092279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Under-grading of <4 cm renal masses on renal biopsy.
    Harris CR; Whitson JM; Meng MV
    BJU Int; 2012 Sep; 110(6):794-7. PubMed ID: 22404857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active surveillance of small renal masses: progression patterns of early stage kidney cancer.
    Jewett MA; Mattar K; Basiuk J; Morash CG; Pautler SE; Siemens DR; Tanguay S; Rendon RA; Gleave ME; Drachenberg DE; Chow R; Chung H; Chin JL; Fleshner NE; Evans AJ; Gallie BL; Haider MA; Kachura JR; Kurban G; Fernandes K; Finelli A
    Eur Urol; 2011 Jul; 60(1):39-44. PubMed ID: 21477920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of percutaneous core biopsy in management of small renal masses.
    Wang R; Wolf JS; Wood DP; Higgins EJ; Hafez KS
    Urology; 2009 Mar; 73(3):586-90; discussion 590-1. PubMed ID: 19118884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the role of percutaneous biopsy in the management of patients with a small renal mass.
    Tan HJ; Jacobs BL; Hafez KS; Montgomery JS; Weizer AZ; Wood DP; Miller DC; Wolf JS
    Urology; 2012 Feb; 79(2):372-7. PubMed ID: 22310755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?
    Jeldres C; Sun M; Liberman D; Lughezzani G; de la Taille A; Tostain J; Valeri A; Cindolo L; Ficarra V; Artibani W; Zigeuner R; Mejean A; Descotes JL; Lechevallier E; Mulders PF; Perrotte P; Patard JJ; Karakiewicz PI
    J Urol; 2009 Dec; 182(6):2585-9. PubMed ID: 19836799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.